Infectomics Screening for Novel Antiviral Drug Targets

Infectomics Screening for Novel Antiviral Drug Targets

Source :

• Drug Development Research [ 0272-4391 ] ; 2012-11.

English descriptors

• Teeft :
  • Activitybased protein, Anal chem, Antimicrobial drug discovery, Antisense inhibitors, Antiviral, Antiviral drug discovery, Antiviral therapy, Apoptosis, Assay, Autophagy, Biol, Biotechnol, Brain tumor cells, Caenorhabditis elegans, Canhua huang, Cell host microbe, Cellular, Cellular functions, Cellular mirnas, Cellular processes, Chem, Chemical genomics, Chemical infectomics, Chemical probes, Clin, Clin microbiol, Collisional activation, Complex proteomes, Critical role, Cultured cells, Curr, Curr drug targets, Cysteine proteases, Dengue, Dengue virus, Denv, Drug discovery, Drug resistance, Drug targets, Escherichia coli bacteriophage, Essential roles, Expert opin, Expression monitoring, Functional genomic analysis, Functional genomic screen, Functional transcription factor, Gene acquisition, Gene expression, Genet, Genome, Genomic, Genomics, Glucose metabolism, Hepatitis, Hepatocellular carcinoma, Hepatoma cells, Hepg2 cells, Herpes simplex virus, Host cell invasion, Host cells, Host factors, Host interactions, Host perspective, Host proteins, Host response, Huang, Human cytomegalovirus, Human genome project, Human host factors, Human proteins, Human virus, Ight mass spectrometry, Important role, Important roles, Infection, Infectious diseases, Infectomics, Infectomics approaches, Infectomics screening, Infectomics view, Inhibitor, Kinase, Large number, Liver hepatitis, Mass proteomics, Membrane receptors, Microarray, Microarray analysis, Microarrays, Microbial, Microbial infections, Microbial pathogens, Microbiol, Microrna, Micrornas, Mirna, Mirnas, Mrna, Mutation, Nonstructural protein, Ns4b protein, Nuclear factor kappa, Nuclear receptors, Omics approaches, Online issue, Opin, Other viruses, Pathogen, Pathway, Physical interaction, Plo, Point mutation, Precore region, Previous studies, Prey proteins, Proc natl acad, Protease, Protease inhibitors, Protein, Protein kinase, Protein microarray analysis, Protein microarrays, Proteome, Proteomic, Proteomic analysis, Proteomic approach, Proteomic approaches, Proteomics, Quantitative analysis, Receptor, Replication, Reporter gene, Rnai, Rnai screen, Rnai screening, Sample consumption, Schematic view, Screening, Sichuan university, Sirna screening, Solid substrate, Spectrometry, Syncytial virus, Systems biology, Transcription, Transcription factors, Tumor suppression, Vaccine, Viral, Viral encoding proteins, Viral infection, Viral infections, Viral perspective, Viral proteins, Viral replication, Viral strategies, Viral transcription, Virol, Virology, Virus, Virus core protein, Virus infection, Virus nonstructural protein, Virus replication, Wang, West china, West china hospital, Wiley periodicals, Yeast, Yeast assay, Yeast host cell, Yeast system, Zhang, Zhou.

Abstract

• https://api.istex.fr/ark:/67375/WNG-K4XR5H06-S/fulltext.pdf

Affiliations:

• République populaire de Chine

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 000F88
• to stream Istex, to step Curation: 000F88
• to stream Istex, to step Checkpoint: 000581
• to stream Main, to step Merge: 001E95
• to stream Main, to step Curation: 001E71

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E71 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E71 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B90474B7CD36BA2935C01CEF5A7D4AEFAC7E4E1D
   |texte=   Infectomics Screening for Novel Antiviral Drug Targets
}}

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021